*** RSVP on Eventbrite: https://www.eventbrite.com/e/getting-insights-from-the-blood-liquid-biopsy-biomarkers-tickets-43721716832 ***
What if a simple blood test could catch diseases before any symptoms show up?
What if you could catch and treat cancer at its earliest stages?
What if you could detect and prevent neurodegenerative diseases?
Companies today are building this future by understanding the biomarkers in our blood to get a window into our health. Come hear about the latest advancements!
Drinks and snacks served.
Elena Helman, Associate Director of Bioinformatics at Guardant Health (http://www.guardanthealth.com/)
Guardant Health has helped thousands of oncologists learn accurate and actionable information about tens of thousands of patients, while avoiding the costs and risks of tissue biopsies. Our genomic test helps match advanced-cancer patients to approved targeted therapies as well as drugs in clinical trials.
Un Kwon-Casado, CEO of Dahlia Biosciences
Leading the next generation of multiplexed in situ single-cell RNA analysis tools for research and diagnostic applications.
David Salzman, CEO of sRNAlytics (https://www.srnalytics.com/)
sRNAlytics has developed a novel bioinformatics platform to identify error-free, small RNA biomarkers. Their Proof-of-Concept work in Huntington’s Disease validated eight biomarkers that are 100% accurate for classifying early vs. late stage disease, and disease progression.
6:30pm Doors open & networking
7:00pm Talks + panel discussion
8:00pm Demos, IndieBio tour, networking